Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06139016 · ClinicalTrials.gov registry record · NA
Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT06139016: Completed NA study, sponsored by Yale University.
NCT06139016 is a NA study that has completed, run by Yale University. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06139016, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Investigators aim to examine the role of audiovisual inputs during treatment with ketamine/esketamine in affecting tolerability and effectiveness of treatment of depressive episodes, by providing patients with a relaxing environment using virtual reality goggles and noise cancelling headphones, and assessing whether these tools can improve the tolerability and effectiveness of treatment with ketamine/esketamine
Primary Outcome
Tolerability of VR treatment will be assessed by qualitative report, an open-ended question where the participant is allowed to describe any concerns not covered by SAFTEE assessment. Data presented here is the number of participants that stated the treatment was Tolerated.
Interventions
- DEVICE Virtual reality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2024-07-11 |
| Est. Completion | 2024-11-27 |
| Phase | NA |
What the finished NCT06139016 record still lists
NCT06139016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Virtual reality is the first listed.
NCT06139016 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06139016 about?
NCT06139016 is a clinical study titled "Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment". Investigators aim to examine the role of audiovisual inputs during treatment with ketamine/esketamine in affecting tolerability and effectiveness of treatment of depressive episodes, by providing patients with a relaxing environment using virtual reality goggles and noise cancelling headphones, and ...
What is the current status of trial NCT06139016?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2024-07-11. Estimated completion is 2024-11-27.
What interventions are being tested in trial NCT06139016?
The interventions under investigation include: Virtual reality (DEVICE).
Who is sponsoring clinical trial NCT06139016?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06139016's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI